Family Medicine · Sumrall, MS
NPI
1942217757
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1238 Highway 42
Sumrall, MS, 39482
Phone (601) 758-3100
Groups this clinician bills Medicare through
Medicare paid, 2024
$210K
11,311 services
Medicare patients, 2024
565
Average age 74
Drug cost, 2024
$803K
16,502 prescriptions
Company payments, 2025
$386
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John D Bullock was code 99490 (chronic, principal, and transitional care management), 1,024 times for 199 patients. In total John D Bullock billed 11,311 services in 86 codes, and Medicare paid $210K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-07-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,024 | 199 | $41.12 | $42K |
| 99214 Office E&M - Established | Office | 682 | 364 | $75.98 | $52K |
| 36415 Venipuncture Blood Collection | Office | 463 | 297 | $8.65 | $4,005 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 448 | 266 | $10.55 | $4,729 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 376 | 376 | $116.92 | $44K |
| 81003 Clinical Chemistry | Office | 203 | 175 | $2.20 | $447 |
| G0008 Administration of influenza virus vaccine | Office | 195 | 192 | $29.46 | $5,745 |
| 90662 Vaccine Product | Office | 184 | 181 | $81.23 | $15K |
| 85025 Blood Count | Office | 180 | 156 | $7.61 | $1,370 |
| 96372 Injection Administration | Office | 159 | 51 | $9.16 | $1,456 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 140 | 15 | $0.70 | $97.57 |
| 83036 Blood Count | Office | 99 | 79 | $9.52 | $942 |
| 99215 Office E&M - Established | Office | 97 | 79 | $120.00 | $12K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 85 | 21 | $0.88 | $74.46 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 57 | 24 | $27.04 | $1,541 |
By year: 2022 $320K for 19,426 services; 2023 $250K for 12,604 services; 2024 $210K for 11,311 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 463 | 297 | $8.65 | $4,005 |
| 81003 Clinical Chemistry | 203 | 175 | $2.20 | $447 |
| 85025 Blood Count | 180 | 156 | $7.61 | $1,370 |
| 83036 Blood Count | 99 | 79 | $9.52 | $942 |
| 80305 Drug Tests | 48 | 24 | $12.35 | $593 |
| 85651 Clinical Chemistry | 12 | 12 | $4.18 | $50.16 |
Medicare prescription drug claims, 2024
In 2024, the drug John D Bullock prescribed most often to Medicare patients was Amlodipine Besylate, with 905 prescriptions and refills. In total John D Bullock wrote 16,502 Medicare prescriptions that cost $803K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 905 | 1,656 | 186 | $3,188 |
| Atorvastatin Calcium Generic | 750 | 1,552 | 162 | $3,915 |
| Rosuvastatin Calcium Generic | 737 | 1,404 | 166 | $4,538 |
| Pantoprazole Sodium Generic | 619 | 1,185 | 134 | $4,525 |
| Irbesartan Generic | 521 | 934 | 103 | $5,472 |
| Losartan Potassium Generic | 457 | 886 | 95 | $3,226 |
| Levothyroxine Sodium Generic | 428 | 689 | 84 | $1,957 |
| Omeprazole Generic | 426 | 783 | 93 | $2,860 |
| Metformin Hcl Generic | 363 | 798 | 83 | $1,512 |
| Gabapentin Generic | 363 | 609 | 103 | $3,638 |
| Famotidine Generic | 337 | 589 | 77 | $1,980 |
| Sertraline Hcl Generic | 298 | 460 | 56 | $1,476 |
| Tizanidine Hcl Generic | 288 | 392 | 81 | $1,400 |
| Potassium Chloride Generic | 271 | 472 | 55 | $2,989 |
| Lisinopril Generic | 228 | 496 | 58 | $762 |
Brand drugs: 1,012 claims; generic drugs: 15,390 claims; opioid claims: 122.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John D Bullock $386 ($386 in general payments such as food, travel and fees) from 10 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $70.38.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 4 | $70.38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $68.26 |
| Abbvie Inc. ABBV | 3 | $58.77 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $41.22 |
| Lilly USA, LLC LLY | 2 | $35.4 |
| Novo Nordisk Inc NVO | 2 | $34.75 |
| Exact Sciences Corporation EXAS | 1 | $23.45 |
| Tris Pharma Inc | 1 | $21.04 |
| Amgen Inc. AMGN | 1 | $19.45 |
| GlaxoSmithKline, LLC. GSK | 1 | $13.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.